Revolutionizing Healthcare: EDAP and Avenda Health Introduce the World’s First AI-Assisted Focal One Robotic HIFU Procedures

First Unfold AI®-Assisted Focal One Procedures Successfully Performed at UCLA School of Medicine Introduction EDAP TMS SA and Avenda Health have teamed up to bring groundbreaking technology to the field of prostate cancer treatment. The collaboration agreement between the two companies focuses on providing personalized care for prostate cancer patients using Avenda Health’s innovative AI…

Read More

Revamping for Success: Cybin’s Share Consolidation is Now Complete!

Revamping for Success: Cybin’s Share Consolidation is Now Complete! Description: TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American: CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that it has filed articles of amendment to consolidate the Company’s…

Read More

Technical Difficulties: CW Petroleum Corp’s Stock Data Not Displaying Correctly on Yahoo Finance and OTC Markets

Katy, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — CW Petroleum Corp (OTCQB: CWPE) Announces Discrepancies in Trade Data The Controversy On September 19, 2024, CW Petroleum Corp, a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, publicly announced that they have been experiencing discrepancies in their daily trade data and price settlements on Yahoo…

Read More

Breaking News: Cathedra Bitcoin Launches C2.5 Million Non-Brokered LIFE Offering!

Cathedra Bitcoin Inc. Announces Private Placement Financing Offering Details Toronto, Ontario–(Newsfile Corp. – September 19, 2024) – (Block Height: 861,930) – Cathedra Bitcoin Inc. (TSXV: CBIT) (OTC Pink: CBTTF) (“Cathedra” or the “Company”), a bitcoin company that develops and operates digital infrastructure assets with the goal of maximizing its per-share bitcoin holdings, is pleased to…

Read More

Oncolytics Biotech Reports Positive Results for Bracelet-1 Breast Cancer Study, Paving the Way for Funding of a Registration-Enabling Study

Oncolytics Biotech Announces Positive Clinical Results from BRACELET-1 Study Introduction The overall survival (OS) results from BRACELET-1 have recently been released, providing valuable insights into the effectiveness of pelareorep-based combination therapy in patients with advanced or metastatic HR+/HER2- breast cancer. Study Results BRACELET-1, a randomized Phase 2 study, demonstrated that over half of the patients…

Read More

Calling All GitLab Investors: Don’t Miss Out on This Opportunity to Lead the Charge in the GitLab Class Action Lawsuit!

Welcome to the GitLab Class Action Lawsuit: A Quirky Dive into Securities Exchange Act Violations Hey there, fellow securities enthusiasts! Have you heard the latest news in the finance world? Robbins Geller Rudman & Dowd LLP just announced that purchasers or acquirers of GitLab Inc. (NASDAQ: GTLB) securities during the Class Period have the opportunity…

Read More

Attention STLA Investors: Robbins Geller Rudman & Dowd LLP Offers Opportunity for Stellantis N.V. Shareholders with Significant Losses to Take the Lead in Legal Action

Robbins Geller Rudman & Dowd LLP Announces Deadline for Stellantis N.V. Investors Overview SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP has recently announced that purchasers or acquirers of Stellantis N.V. (NYSE: STLA) securities between February 15, 2024 and July 24, 2024, inclusive (the “Class Period”), have until October…

Read More